Somewhat Favorable Media Coverage Somewhat Unlikely to Impact HCP (HCP) Stock Price
News stories about HCP (NYSE:HCP) have been trending somewhat positive this week, Accern Sentiment reports. The research group rates the sentiment of media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. HCP earned a news impact score of 0.20 on Accern’s scale. Accern also gave news headlines about the real estate investment trust an impact score of 47.3342040350915 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Here are some of the headlines that may have effected Accern Sentiment Analysis’s rankings:
- US nursing home chain faces landlord showdown over default (GEN, HCP, VTR, SBRA, HCN, OHI) – Markets Insider (markets.businessinsider.com)
- Long Island Premiere Of “Reversing The Stigma” To Take Place At Bay Street (hamptons.com)
- Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Files An 8-K Results of Operations and Financial Condition (4-traders.com)
- TANDEM DIABETES CARE INC : Results of Operations and Financial Condition (form 8-K) (4-traders.com)
A number of research analysts have recently commented on the stock. BidaskClub raised shares of HCP from a “hold” rating to a “buy” rating in a report on Wednesday, June 21st. Jefferies Group LLC reissued a “hold” rating and issued a $33.00 target price on shares of HCP in a report on Tuesday, July 25th. Royal Bank Of Canada reissued a “hold” rating and issued a $31.00 target price on shares of HCP in a report on Wednesday, July 5th. Bank of America Corporation cut shares of HCP from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $33.00 to $31.00 in a report on Friday, September 22nd. Finally, Zacks Investment Research cut shares of HCP from a “hold” rating to a “sell” rating in a report on Tuesday, July 18th. Four research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and one has issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $31.27.
HCP (NYSE:HCP) opened at 26.22 on Tuesday. The company has a market cap of $12.30 billion, a price-to-earnings ratio of 17.87 and a beta of 0.38. HCP has a one year low of $26.18 and a one year high of $34.02. The company has a 50-day moving average of $28.48 and a 200-day moving average of $30.59.
HCP (NYSE:HCP) last issued its earnings results on Tuesday, August 1st. The real estate investment trust reported $0.48 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.47 by $0.01. The business had revenue of $458.90 million during the quarter, compared to analyst estimates of $456.29 million. HCP had a return on equity of 9.96% and a net margin of 32.16%. HCP’s revenue for the quarter was down 14.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.71 earnings per share. Equities research analysts expect that HCP will post $1.34 EPS for the current fiscal year.
HCP Company Profile
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.